Arla Foods Ingredients (AFI) is strengthening its focus on medical nutrition with the launch of new micellar casein isolate (MCI) solutions targeting a growing global market.

The company has expanded its MCI product range with the introduction of Lacprodan® MicelPure® Medical, specifically developed for medical nutrition. Extracted gently from milk, MCI is naturally rich in high-quality protein, making it ideal for addressing malnutrition—an issue affecting up to 70% of cancer patients and elderly individuals worldwide.

The new product features an optimized mineral profile and superior microbiological quality, meeting the stringent requirements of clinical nutrition. Additionally, AFI’s MCI ingredients offer a neutral taste, low viscosity, and high heat stability, making them easy to incorporate into both oral nutritional supplements and tube feeding products, including UHT-treated and shelf-stable formats.

Market data shows that 30–52% of new nutritional products are aimed at combating malnutrition, and the sector is expected to grow by 5% annually through 2027. Arla emphasizes that improved taste and texture can enhance patient compliance with nutrition plans, ultimately supporting better recovery outcomes and quality of life. The new solutions will be showcased

Read the full press release here.

Photo: AFI